Last updated: 11/03/2018 22:28:20
Efficacy of a carbohydrate drink on speed, agility and power in school going children
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Efficacy of a carbohydrate drink on speed, agility and power in school going children
Trial description: The purpose of this study is to investigate the impact of a beverage containing carbohydrate powder fortified with micronutrients on agility, speed, and power in school going children
Primary purpose:
Other
Trial design:
Crossover Assignment
Masking:
Single (Investigator)
Allocation:
Randomized
Primary outcomes:
Change from baseline in Agility fatigue index
Timeframe: Baseline and 4h post-baseline
Secondary outcomes:
Change from baseline in Speed fatigue index
Timeframe: Baseline and 4h post-baseline
Change from baseline in Mean power output
Timeframe: Baseline and 4h post-baseline
Interventions:
Enrollment:
30
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
http://www.i-scholar.in/index.php/Ijnd/article/view/130266
Morris, T. E., Bhoite, R., Karwal, R., V., B., K., & A. (2017, March 01). Micronutrient Fortified Carbohydrate Supplementation and Speed, Agility and Power in Indian Adolescent Athletes. The Indian Journal of Nutrition and Dietetics, Vol 54 No (1 2017), Pages 1-12
Medical condition
Growth and Development
Product
Not applicable
Collaborators
Not applicable
Study date(s)
May 2015 to May 2015
Type
Interventional
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
12 - 15 years
Accepts healthy volunteers
Yes
- Informed consent by participant's parents or legally accepted representative
- Good general health
- Child in care
- Allergy/Intolerance to study materials
Inclusion and exclusion criteria
Inclusion criteria:
- Informed consent by participant's parents or legally accepted representative
- Good general health
- Non anemic children (Hb≥12 g/dl)
- Academy/development level athlete (at least 3 activity sessions per week, for a minimum of 2 hours of activity in each session e.g. hockey, football, team sports)
Exclusion criteria:
- Child in care
- Allergy/Intolerance to study materials
- History of cardiovascular disorder, respiratory diseases, diabetes mellitus, serious infection/injuries/surgeries (within past 3 months)
- Participation in any nutritional study in past 1 year
- Substance abuse
- Children on any kind of medication in past 1 month of screening
Trial location(s)
Study documents
Statistical analysis plan
Available language(s): English
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
Protocol
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2015-30-05
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website